12 past transactions

Your Name Here

Series A in 2021
Your Name Here is a fashion designer that sells t-shirts and jeans.

MILK Makeup

Venture Round in 2019
MILK Makeup is a beauty essential supplier with a new trend using high-tech formulas for the girl on the go. The company was founded in 2014 and is based in New York, USA.

TOUN28

Series A in 2019
TOUN28 is a manufacturer and supplier of organic skincare products intended to provide healthy change in skin conditions.

BlockOdyssey

Seed Round in 2018
BlockOdyssey is a tech start-up that provides 'blockchain-based B2B solutions'. Currently, the main solution is supplying 'blockchain-based anti-counterfeiting solution', and logistics & distribution history management is in progress with blockchain. It has received investment from Asia's largest cosmetic company, and is conducting business with French pharmaceutical companies.

Elastagen

Series B in 2016
Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen has developed a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.

WayWearable

Venture Round in 2015
WayWearable, a ‘beauty-appliance’ company based in Seoul, Korea, has created the first total personal skincare companion that fits in your purse. The WAY device is the size of a compact powder case, but includes an array of advanced biometric and environmental sensors that it uses to make personalized skincare recommendations through its companion app. Developed in close consultation with a dermatologist, WAY helps people make smarter skincare decisions that last a lifetime. They recently joined Sparklabs, one of Asia’s top business accelerators, to bring their unique technology product to market and have kicked off an Indiegogo campaign to fund production. Their Vision - WayWearble is dedicated to improving the lives of women, by helping them more effectively manage their skin care routine, and ultimately improve health and well-being. While WAY is a first step, the company has ambitions to continue developing innovative new products that harness advances in technology, with a particular focus on the women’s health and beauty industry. In the future WayWearable will continue to develop their solutions for making more targeted and accurate suggestions of specific products that address the unique skin concerns of women, while providing deeper, personal insights into maintaining a healthy lifestyle.

TRIA Beauty

Private Equity Round in 2013
TRIA Beauty develops and markets light-based therapeutic beauty systems for the consumer market. The company provides a diode laser hair removal system for home use. It offers its products through a network of retailers.

Brickell Biotech

Series B in 2013
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell’s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®.

Neothetics

Series C in 2012
Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market.

Evofem Biosciences

Series C in 2012
Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.

Obalon Therapeutics

Venture Round in 2012
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.